[1]
S. Kinos, “Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)”, AO, vol. 63, no. 1, pp. 248–258, May 2024.